Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent ...
FOX 5 Atlanta on MSN11d
Hidradenitis Suppurativa: Often misdiagnosed, especially among Black women
Hidradenitis Suppurativa (HS) is getting increased attention from dermatologists due to its frequent misdiagnosis and ...
KHQ15d
Spokane man battles rare skin condition perplexing Johns Hopkins doctors
Just before his 38th birthday, doctor believed Becker's condition is Pyoderma Gangrenosum (PG), a rare disorder causing large, painful sores on the skin. The Mayo Clinic notes that these sores can ...
stomp.straitstimes16d
Patients suffering from rare skin disease deal with 'insensitive questions and funny stares'
Prof Koh is a co-founder of Rare Skin Conditions Society Singapore (RSCS), which was established in 2017 to create a support group for patients and families with genetic and incurable rare skin ...
CNN16d
Prince Frederik of Luxembourg dies from rare disease
“Though Prince Frederik always made it very clear that he did not want the dreadful disease to define him, he devoted himself to spreading awareness on the rare disease,” the family ...
Prevention17d
At 50, Chelsea Handler Reveals the Affordable Body Lotion That Gives Her ‘Very, Very Soft Skin’
“I moisturize all parts of my body, and it pays off. I have very, very soft skin.” “I wear Gold Bond when I’m skiing or doing anything outdoors,” Handler added. “That helps protect ...
Business Insider21d
JD Health Expands Rare Disease Support, Assists Over 23,000 Patients via Joint Charity Programs
March 4, 2025-- In observance of Rare Disease Day on February 28, JD Health hosted the 4th Rare Disease Service Ecosystem Forum in Beijing. At the event, JD Health, in partnership with the Aili ...
pharmaphorum21d
FDA grants speedy review to Dupixent rare skin disease
Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN).
Nasdaq22d
Quoin Pharmaceuticals Files Patent Applications for Topical Rapamycin Formulations Targeting Rare Skin Diseases
The proprietary Invisicare delivery technology has exclusive rights for all orphan rare skin disease applications, enhancing Quoin's competitive advantage in the pharmaceutical market. The company ...
Mena FN22d
Quoin Pharmaceuticals Files U.S. And International Patent Applications For Novel Topical Rapamycin Formulations To Treat Rare Disease Indications
The proprietary Invisicare delivery technology, which Quoin has exclusive rights to for all orphan rare skin disease applications, is designed to optimize penetration of rapamycin deep into dermis ...
Yahoo Finance22d
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
ASHBURN, Va., March 04, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty ...